SlideShare a Scribd company logo
1 of 15
Overview of Biological Products
FDA Basics Webinar
June 17, 2013
Mantej (Nimi) Chhina, M.S., Ph.D.
Health Science Policy Analyst
Office of Medical Policy
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Objectives
• Biological products definition
• What is a “biological product”?
• Sources for biological products
• Types of biological products
• How are biological products different?
• Questions from consumers and patients
2
Definition of Biological Product
Section 351, Public Health Service (PHS) Act
– (1) The term “biological product” means a virus,
therapeutic serum, toxin, antitoxin, vaccine, blood, blood
component or derivative, allergenic product, protein
(except any chemically synthesized polypeptide), or
analogous product, or arsphenamine or derivative of
arsphenamine (or any other trivalent organic arsenic
compound), applicable to the prevention, treatment, or
cure of a disease or condition of human beings.
42 U.S.C. § 262(i)
3
Examples of Biological Products
• Biological products are used for a wide range of diseases and
conditions, including serious and life-threatening conditions
such as cancers and rheumatoid arthritis. Some examples of
biological products and examples of their approved uses
include:
Botox: has both dermatologic and neurologic uses
Herceptin: for a certain type of breast cancer
Vaccines, for example: the Shingles vaccine and the flu
vaccines
Enbrel: for rheumatoid arthritis and psoriasis
4
What is a Biological Product?
5
• Biological products, or biologics, are medical products.
• Biological products could be made of sugars, proteins, or nucleic acids
or complex combinations of these substances, or may be living entities
such as cells and tissues.
• Like drugs, biological products are used to either:
 treat or cure diseases and medical conditions,
 prevent diseases, or
 diagnose diseases
• Biological products are made from a variety of natural sources.
Source Materials
6
Mice
Humans
Bacteria
Insect cell-culture
Transgenics
Yeast
Mammalian cell-culture
Plant cell-culture
Avian
cell-culture
Types of Biological Products
Blood Derivatives
Proteins
Whole Blood
Human Tissues Xenotransplantation
Products
Vaccines (preventive
and therapeutic)
Allergenic
ExtractsBlood
Components
Cellular &
Gene
Therapies
7
How are Biological Products Different?
8
Small Molecule Drugs Biological Products
Generally low molecular weight Generally high molecular weight
Usually organic or chemical
synthesis
Made with/from live cells/organisms
 inherent & contamination risk
Fewer critical process steps Many critical process steps
Well-characterized Less easily characterized
Known structure Structure may or may not be
completely defined or known
Homogeneous drug substance Heterogeneous mixtures
 May include variants
Usually not immunogenic Often Immunogenic
Aspirin 180 Da
Monoclonal Antibody ~150,000 Da 9
Size and Complexity of Proteins
Example of a Biotechnology Process
Harvest
Protein
mixture
Concentration
Formulation
Filling
Fermentor
Columns Purify Protein
Live
cells Biological Drug Substance
Biological Drug Product
10
Examples of Challenges for
Biological Products
• Must be processed under tightly controlled
conditions/controls throughout production to
– consistently produce a safe, pure, and potent product, and
– preclude the introduction of environmental contamination
• Biological products may be susceptible to extreme
temperatures and light
• typically need refrigeration but may need frozen storage or
preservatives
• shelf life may be limited
11
Bringing a biological product to the US market
• A manufacturer who seeks to market a biological product must
submit a biologics license application (BLA), which includes:
– Manufacturing information to demonstrate the company can properly and
consistently manufacture the biological product
– Data and information regarding the biological product (e.g., studies in animals
and humans)
– The company’s proposed labeling for the biological product. The labeling
provides necessary information about the biological product, including uses for
which it has been shown to be effective, possible risks, and how to use it.
• The biological product is licensed and can be marketed in the United
States only if
– FDA determines that the data shows the biological product is safe and effective
for its proposed use, and
– the biological product can be manufactured in a way that ensures a quality
product. 12
Summary
• Biological Products: diverse, complex products for the
treatment, diagnosis and prevention of a broad range of
common and rare diseases
• Complex processes for manufacturing, product testing, and
for evaluation of safety and efficacy
• In contrast to most drugs that are chemically synthesized and
have a known structure, most biological products are
complex mixtures that are not as easily identified or
characterized.
• Healthcare professionals and consumers can be assured that
FDA will require licensed biological products to meet the
Agency’s exacting standards of safety and effectiveness.
13
Thank you!
Questions?
14
Remember to tune in for webinar on:
Biosimilar Biological Products
Monday, August 19, 2013
1:00 PM U.S. Eastern Time Zone
15

More Related Content

What's hot

Regulatory Affairs.
Regulatory Affairs.Regulatory Affairs.
Regulatory Affairs.
Naila Kanwal
 
Federal food, drug & cosmetics act
Federal food, drug & cosmetics actFederal food, drug & cosmetics act
Federal food, drug & cosmetics act
Jamia Hamdard
 

What's hot (20)

Common Technical Document (CTD)
Common Technical Document (CTD)Common Technical Document (CTD)
Common Technical Document (CTD)
 
Regulatory Affairs.
Regulatory Affairs.Regulatory Affairs.
Regulatory Affairs.
 
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptxBasics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 
Drug regulatory authority
Drug regulatory authority Drug regulatory authority
Drug regulatory authority
 
Ich guidelines
Ich guidelinesIch guidelines
Ich guidelines
 
Regulatory aspects
Regulatory aspectsRegulatory aspects
Regulatory aspects
 
Biosimilars and generics
Biosimilars and genericsBiosimilars and generics
Biosimilars and generics
 
Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India
 
Federal food, drug & cosmetics act
Federal food, drug & cosmetics actFederal food, drug & cosmetics act
Federal food, drug & cosmetics act
 
INDA/NDA/ANDA
INDA/NDA/ANDAINDA/NDA/ANDA
INDA/NDA/ANDA
 
central and state Regulatory bodies in India
central and state Regulatory bodies in Indiacentral and state Regulatory bodies in India
central and state Regulatory bodies in India
 
Nda and Anda
Nda and AndaNda and Anda
Nda and Anda
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 
ICH AND ICH GUIDELINES
ICH AND ICH GUIDELINESICH AND ICH GUIDELINES
ICH AND ICH GUIDELINES
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
 
Biosimilars
Biosimilars Biosimilars
Biosimilars
 
Registration requirments for cis countries
Registration requirments for cis countriesRegistration requirments for cis countries
Registration requirments for cis countries
 
Biologicals
BiologicalsBiologicals
Biologicals
 

Similar to FDA Presentation on Biologics

different biological product and difference between biosimilllar and generic
different biological product and difference between biosimilllar and genericdifferent biological product and difference between biosimilllar and generic
different biological product and difference between biosimilllar and generic
Charmi13
 
What is biologic, biosimilar, and biobetter
What is biologic, biosimilar, and biobetterWhat is biologic, biosimilar, and biobetter
What is biologic, biosimilar, and biobetter
Naveen Kumar Singh, Ph.D.
 
Pegylation & biosimilars global scenario
Pegylation & biosimilars   global scenarioPegylation & biosimilars   global scenario
Pegylation & biosimilars global scenario
Malay Singh
 
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Prof. Dr. Basavaraj Nanjwade
 

Similar to FDA Presentation on Biologics (20)

different biological product and difference between biosimilllar and generic
different biological product and difference between biosimilllar and genericdifferent biological product and difference between biosimilllar and generic
different biological product and difference between biosimilllar and generic
 
USFDA NDA Vs BLA
USFDA NDA Vs BLAUSFDA NDA Vs BLA
USFDA NDA Vs BLA
 
Regulatory Requirement for the Product Approval of Biologics Ppt.pptx
Regulatory Requirement for the Product Approval of Biologics Ppt.pptxRegulatory Requirement for the Product Approval of Biologics Ppt.pptx
Regulatory Requirement for the Product Approval of Biologics Ppt.pptx
 
What is biologic, biosimilar, and biobetter
What is biologic, biosimilar, and biobetterWhat is biologic, biosimilar, and biobetter
What is biologic, biosimilar, and biobetter
 
concept of biosimilars
concept of biosimilarsconcept of biosimilars
concept of biosimilars
 
Pegylation & biosimilars global scenario
Pegylation & biosimilars   global scenarioPegylation & biosimilars   global scenario
Pegylation & biosimilars global scenario
 
Biosimilars
BiosimilarsBiosimilars
Biosimilars
 
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
 
Ethical Consideration in Bioequivalence studies.pptx
Ethical Consideration in Bioequivalence studies.pptxEthical Consideration in Bioequivalence studies.pptx
Ethical Consideration in Bioequivalence studies.pptx
 
DDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.pptDDS DRUGS AND DOSAGE FORMS-2020.ppt
DDS DRUGS AND DOSAGE FORMS-2020.ppt
 
FDA 2013 Clinical Investigator Training Course: Biosimilar Biological Products
FDA 2013 Clinical Investigator Training Course: Biosimilar Biological ProductsFDA 2013 Clinical Investigator Training Course: Biosimilar Biological Products
FDA 2013 Clinical Investigator Training Course: Biosimilar Biological Products
 
Labelling of irradiated food and organic food
Labelling of irradiated food and organic foodLabelling of irradiated food and organic food
Labelling of irradiated food and organic food
 
Regulatory requirements for the product
Regulatory requirements for the productRegulatory requirements for the product
Regulatory requirements for the product
 
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
 
Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)
 
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...
 
Reg.IssuesCRO.tripati.ppt
Reg.IssuesCRO.tripati.pptReg.IssuesCRO.tripati.ppt
Reg.IssuesCRO.tripati.ppt
 
biotechnology regulations.ppt
biotechnology regulations.pptbiotechnology regulations.ppt
biotechnology regulations.ppt
 
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
 
Biopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
Biopharmaceutical Products, GMP, Manufacturing Facilities for BiopharmaceuticalsBiopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
Biopharmaceutical Products, GMP, Manufacturing Facilities for Biopharmaceuticals
 

Recently uploaded

Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slide
vu2urc
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
giselly40
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI Solutions
Enterprise Knowledge
 

Recently uploaded (20)

Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreter
 
08448380779 Call Girls In Greater Kailash - I Women Seeking Men
08448380779 Call Girls In Greater Kailash - I Women Seeking Men08448380779 Call Girls In Greater Kailash - I Women Seeking Men
08448380779 Call Girls In Greater Kailash - I Women Seeking Men
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slide
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
Raspberry Pi 5: Challenges and Solutions in Bringing up an OpenGL/Vulkan Driv...
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
What Are The Drone Anti-jamming Systems Technology?
What Are The Drone Anti-jamming Systems Technology?What Are The Drone Anti-jamming Systems Technology?
What Are The Drone Anti-jamming Systems Technology?
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
Breaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountBreaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path Mount
 
The Codex of Business Writing Software for Real-World Solutions 2.pptx
The Codex of Business Writing Software for Real-World Solutions 2.pptxThe Codex of Business Writing Software for Real-World Solutions 2.pptx
The Codex of Business Writing Software for Real-World Solutions 2.pptx
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI Solutions
 
Advantages of Hiring UIUX Design Service Providers for Your Business
Advantages of Hiring UIUX Design Service Providers for Your BusinessAdvantages of Hiring UIUX Design Service Providers for Your Business
Advantages of Hiring UIUX Design Service Providers for Your Business
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024
 
Boost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivityBoost PC performance: How more available memory can improve productivity
Boost PC performance: How more available memory can improve productivity
 

FDA Presentation on Biologics

  • 1. Overview of Biological Products FDA Basics Webinar June 17, 2013 Mantej (Nimi) Chhina, M.S., Ph.D. Health Science Policy Analyst Office of Medical Policy Center for Drug Evaluation and Research U.S. Food and Drug Administration
  • 2. Objectives • Biological products definition • What is a “biological product”? • Sources for biological products • Types of biological products • How are biological products different? • Questions from consumers and patients 2
  • 3. Definition of Biological Product Section 351, Public Health Service (PHS) Act – (1) The term “biological product” means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of a disease or condition of human beings. 42 U.S.C. § 262(i) 3
  • 4. Examples of Biological Products • Biological products are used for a wide range of diseases and conditions, including serious and life-threatening conditions such as cancers and rheumatoid arthritis. Some examples of biological products and examples of their approved uses include: Botox: has both dermatologic and neurologic uses Herceptin: for a certain type of breast cancer Vaccines, for example: the Shingles vaccine and the flu vaccines Enbrel: for rheumatoid arthritis and psoriasis 4
  • 5. What is a Biological Product? 5 • Biological products, or biologics, are medical products. • Biological products could be made of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. • Like drugs, biological products are used to either:  treat or cure diseases and medical conditions,  prevent diseases, or  diagnose diseases • Biological products are made from a variety of natural sources.
  • 7. Types of Biological Products Blood Derivatives Proteins Whole Blood Human Tissues Xenotransplantation Products Vaccines (preventive and therapeutic) Allergenic ExtractsBlood Components Cellular & Gene Therapies 7
  • 8. How are Biological Products Different? 8 Small Molecule Drugs Biological Products Generally low molecular weight Generally high molecular weight Usually organic or chemical synthesis Made with/from live cells/organisms  inherent & contamination risk Fewer critical process steps Many critical process steps Well-characterized Less easily characterized Known structure Structure may or may not be completely defined or known Homogeneous drug substance Heterogeneous mixtures  May include variants Usually not immunogenic Often Immunogenic
  • 9. Aspirin 180 Da Monoclonal Antibody ~150,000 Da 9 Size and Complexity of Proteins
  • 10. Example of a Biotechnology Process Harvest Protein mixture Concentration Formulation Filling Fermentor Columns Purify Protein Live cells Biological Drug Substance Biological Drug Product 10
  • 11. Examples of Challenges for Biological Products • Must be processed under tightly controlled conditions/controls throughout production to – consistently produce a safe, pure, and potent product, and – preclude the introduction of environmental contamination • Biological products may be susceptible to extreme temperatures and light • typically need refrigeration but may need frozen storage or preservatives • shelf life may be limited 11
  • 12. Bringing a biological product to the US market • A manufacturer who seeks to market a biological product must submit a biologics license application (BLA), which includes: – Manufacturing information to demonstrate the company can properly and consistently manufacture the biological product – Data and information regarding the biological product (e.g., studies in animals and humans) – The company’s proposed labeling for the biological product. The labeling provides necessary information about the biological product, including uses for which it has been shown to be effective, possible risks, and how to use it. • The biological product is licensed and can be marketed in the United States only if – FDA determines that the data shows the biological product is safe and effective for its proposed use, and – the biological product can be manufactured in a way that ensures a quality product. 12
  • 13. Summary • Biological Products: diverse, complex products for the treatment, diagnosis and prevention of a broad range of common and rare diseases • Complex processes for manufacturing, product testing, and for evaluation of safety and efficacy • In contrast to most drugs that are chemically synthesized and have a known structure, most biological products are complex mixtures that are not as easily identified or characterized. • Healthcare professionals and consumers can be assured that FDA will require licensed biological products to meet the Agency’s exacting standards of safety and effectiveness. 13
  • 15. Remember to tune in for webinar on: Biosimilar Biological Products Monday, August 19, 2013 1:00 PM U.S. Eastern Time Zone 15